公司资料
Butterfly Network 股价、新闻与催化剂
- 股票代码:
- BFLY
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
8.95 USD (+4.92%)
收盘价
最后更新: 2026年10月2日
1.2B USD
市值
股价为何变动
截至 2026年10月2日，BFLY 上涨 4.92%，收于 $8.95。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Point-of-Care Ultrasound Platform
Butterfly Network develops portable ultrasound systems intended to make medical imaging available wherever clinical decisions are made. Its platform combines handheld hardware, enterprise software, and artificial intelligence for use across hospitals, clinics, emergency settings, medical education, and other care environments.
Ultrasound-on-Chip Hardware
The Butterfly iQ family uses a semiconductor-based transducer architecture that replaces the multiple probes commonly required by conventional ultrasound systems. The current iQ3 device is designed as a single-probe, whole-body system that connects to a mobile device and supports a broad range of scanning applications.
Compass Software and AI
Butterfly Compass provides image acquisition, workflow management, documentation, credentialing, and enterprise connectivity. Compass AI adds guidance and measurement tools intended to help clinicians acquire diagnostic-quality images and standardize ultrasound use across different levels of experience.
Health-System and Education Customers
The company sells devices and software subscriptions to health systems, individual clinicians, medical schools, and international distributors. Enterprise deployments can place ultrasound across multiple departments while giving administrators centralized control over users, data, and clinical workflows.
Butterfly Embedded
Butterfly Embedded licenses the company's ultrasound technology to third parties developing their own medical devices and applications. This model extends the Ultrasound-on-Chip architecture beyond Butterfly-branded products through development collaborations, licensing, and potential component or software revenue.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。